Testing effectiveness (Phase 2)Ended earlyNCT05325866
What this trial is testing
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Who this might be right for
Solid Tumors
Amgen 260
Showing 20 of 0 results